Published 20:02 IST, November 9th 2020
Pfizer, BioNTech seek EUA as COVID-19 vaccine shows over 90% efficacy; here's what's next
As Pfizer-BioNTech COVID-19 vaccine showed more than 90 per cent efficacy, the preliminary results have now paved the way for the companies to seek an EUA.
null | Image:
self
Advertisement
20:03 IST, November 9th 2020